Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $5.9700 (-2.13%) ($5.9400 - $6.1500) on Thu. Jun. 13, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.81% (three month average) | RSI | 30 | Latest Price | $5.9700(-2.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -2.4% a day on average for past five trading days. | Weekly Trend | CEMI declines -4.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) ARKG(11%) XBI(8%) IGOV(7%) SHY(7%) ARKK(5%) | Factors Impacting CEMI price | CEMI will decline at least -1.405% in a week (0% probabilities). UNG(-11%) IFRA(-7%) XLP(-5%) VXX(-5%) XOP(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.405% (StdDev 2.81%) | Hourly BBV | 0 () | Intraday Trend | -2.9% | | | |
|
1 - 5 Day Possible Target | $-8.7(-245.73%) | Resistance Level | $6.82 | 5 Day Moving Average | $6.24(-4.33%) | 10 Day Moving Average | $6.49(-8.01%) | 20 Day Moving Average | $6.82(-12.46%) | To recent high | -23.9% | To recent low | 12.2% | Market Cap | $120m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |